Matches in SemOpenAlex for { <https://semopenalex.org/work/W1980757029> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W1980757029 endingPage "1139" @default.
- W1980757029 startingPage "1136" @default.
- W1980757029 abstract "Purpose To evaluate the efficacy and safety of topical imiquimod 5% cream for the treatment of eyelid basal cell carcinoma. Design Two interventional case reports. Methods Imiquimod 5% cream was applied topically once daily, 3 days a week for 8 to 12 weeks, in two patients affected by eyelid nodular basal cell carcinoma. Patients were followed up clinically with slit-lamp examination for evidence of tumor disappearance or recurrence, and local and systemic side effects. Results Complete clinical response was obtained in both patients. No severe local side effects were observed. Patients did not show any local recurrence after 1 year. Conclusions Topical imiquimod 5% cream seems to be a useful treatment for eyelid nodular basal cell carcinoma in selected cases, but further long-term studies are needed to assess the efficacy and safety of this approach. To evaluate the efficacy and safety of topical imiquimod 5% cream for the treatment of eyelid basal cell carcinoma. Two interventional case reports. Imiquimod 5% cream was applied topically once daily, 3 days a week for 8 to 12 weeks, in two patients affected by eyelid nodular basal cell carcinoma. Patients were followed up clinically with slit-lamp examination for evidence of tumor disappearance or recurrence, and local and systemic side effects. Complete clinical response was obtained in both patients. No severe local side effects were observed. Patients did not show any local recurrence after 1 year. Topical imiquimod 5% cream seems to be a useful treatment for eyelid nodular basal cell carcinoma in selected cases, but further long-term studies are needed to assess the efficacy and safety of this approach." @default.
- W1980757029 created "2016-06-24" @default.
- W1980757029 creator A5018194394 @default.
- W1980757029 creator A5021151057 @default.
- W1980757029 creator A5078414485 @default.
- W1980757029 date "2005-12-01" @default.
- W1980757029 modified "2023-09-30" @default.
- W1980757029 title "Immunotherapy With Imiquimod 5% Cream for Eyelid Nodular Basal Cell Carcinoma" @default.
- W1980757029 cites W1766190924 @default.
- W1980757029 cites W1972776583 @default.
- W1980757029 cites W1975300769 @default.
- W1980757029 cites W1985299393 @default.
- W1980757029 cites W1996136370 @default.
- W1980757029 cites W2150398924 @default.
- W1980757029 doi "https://doi.org/10.1016/j.ajo.2005.06.057" @default.
- W1980757029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16376667" @default.
- W1980757029 hasPublicationYear "2005" @default.
- W1980757029 type Work @default.
- W1980757029 sameAs 1980757029 @default.
- W1980757029 citedByCount "37" @default.
- W1980757029 countsByYear W19807570292012 @default.
- W1980757029 countsByYear W19807570292015 @default.
- W1980757029 countsByYear W19807570292017 @default.
- W1980757029 countsByYear W19807570292019 @default.
- W1980757029 countsByYear W19807570292020 @default.
- W1980757029 countsByYear W19807570292021 @default.
- W1980757029 countsByYear W19807570292022 @default.
- W1980757029 crossrefType "journal-article" @default.
- W1980757029 hasAuthorship W1980757029A5018194394 @default.
- W1980757029 hasAuthorship W1980757029A5021151057 @default.
- W1980757029 hasAuthorship W1980757029A5078414485 @default.
- W1980757029 hasConcept C126322002 @default.
- W1980757029 hasConcept C141071460 @default.
- W1980757029 hasConcept C142724271 @default.
- W1980757029 hasConcept C16005928 @default.
- W1980757029 hasConcept C2777546739 @default.
- W1980757029 hasConcept C2778024521 @default.
- W1980757029 hasConcept C2778804307 @default.
- W1980757029 hasConcept C2779112978 @default.
- W1980757029 hasConcept C2779306644 @default.
- W1980757029 hasConcept C2781302119 @default.
- W1980757029 hasConcept C3019992690 @default.
- W1980757029 hasConcept C71924100 @default.
- W1980757029 hasConceptScore W1980757029C126322002 @default.
- W1980757029 hasConceptScore W1980757029C141071460 @default.
- W1980757029 hasConceptScore W1980757029C142724271 @default.
- W1980757029 hasConceptScore W1980757029C16005928 @default.
- W1980757029 hasConceptScore W1980757029C2777546739 @default.
- W1980757029 hasConceptScore W1980757029C2778024521 @default.
- W1980757029 hasConceptScore W1980757029C2778804307 @default.
- W1980757029 hasConceptScore W1980757029C2779112978 @default.
- W1980757029 hasConceptScore W1980757029C2779306644 @default.
- W1980757029 hasConceptScore W1980757029C2781302119 @default.
- W1980757029 hasConceptScore W1980757029C3019992690 @default.
- W1980757029 hasConceptScore W1980757029C71924100 @default.
- W1980757029 hasIssue "6" @default.
- W1980757029 hasLocation W19807570291 @default.
- W1980757029 hasLocation W19807570292 @default.
- W1980757029 hasOpenAccess W1980757029 @default.
- W1980757029 hasPrimaryLocation W19807570291 @default.
- W1980757029 hasRelatedWork W139793809 @default.
- W1980757029 hasRelatedWork W1599046227 @default.
- W1980757029 hasRelatedWork W1883165868 @default.
- W1980757029 hasRelatedWork W1980757029 @default.
- W1980757029 hasRelatedWork W1983696229 @default.
- W1980757029 hasRelatedWork W2087172039 @default.
- W1980757029 hasRelatedWork W2304381409 @default.
- W1980757029 hasRelatedWork W2521438873 @default.
- W1980757029 hasRelatedWork W4317567090 @default.
- W1980757029 hasRelatedWork W1832072569 @default.
- W1980757029 hasVolume "140" @default.
- W1980757029 isParatext "false" @default.
- W1980757029 isRetracted "false" @default.
- W1980757029 magId "1980757029" @default.
- W1980757029 workType "article" @default.